Jove
Visualize
Contact Us

Related Experiment Videos

Historical perspectives on inotropic agents.

A E Farah

    Circulation
    |March 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Digitalis glycosides and other positive inotropic agents have varying effects on heart function. Recent discoveries of new inotropic agents offer revised therapeutic strategies for congestive heart failure.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The influence of rate of administration upon the lethal dose of cardiac glycosides.

    The Journal of pharmacology and experimental therapeutics·2010
    Same author

    Prevalence of hepatitis B surface antigen in pregnant Lebanese women.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·1997
    Same author

    Hepatitis C virus antibodies in pregnant Lebanese women.

    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·1997
    Same author

    The role of cyclic AMP and the dihydropyridine-sensitive channels on the mechanism of action of milrinone (Corotrope).

    Journal of cardiovascular pharmacology·1989
    Same author

    Seroepidemiology of the human immunodeficiency virus in Lebanon. Preliminary evaluation.

    Le Journal medical libanais. The Lebanese medical journal·1989
    Same author

    Clinical and serological study of the human immunodeficiency virus infection in a cohort of multitransfused persons.

    Le Journal medical libanais. The Lebanese medical journal·1989
    Same journal

    Eugene Braunwald, MD, 1929-2026.

    Circulation·2026
    Same journal

    AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

    Circulation·2026
    Same journal

    Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.

    Circulation·2026
    Same journal

    Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.

    Circulation·2026
    Same journal

    Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

    Circulation·2026
    Same journal

    Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

    Circulation·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Early research on digitalis glycosides suggested they only improved cardiac output in failing hearts.
    • Subsequent studies indicated these cardiotonic agents also affect normal hearts by increasing systolic pressure and reducing relaxation time.

    Observation:

    • The precise mechanism of digitalis (peripheral vascular vs. direct cardiac effects) was clarified using advanced methods to assess intraventricular pressures and cardiac contractile force.
    • Adrenergic agonists, while positive inotropic agents for heart failure, show diminishing effectiveness with long-term therapy.
    • Glucagon, another positive inotropic agent, has demonstrated side effects and limited efficacy in chronic heart failure.

    Findings:

    • Newer inotropic agents, including bipyridines and imidazole/benzimidazole derivatives, have emerged.

    Related Experiment Videos

  • These novel agents are prompting a re-evaluation of current congestive heart failure treatment approaches.

    • Implications:

    • The development of novel inotropic agents signifies a potential shift in managing congestive heart failure.
    • Further research into these new drug classes may lead to more effective and sustained treatments for heart failure patients.